Related Experiment Video
Updated: May 13, 2026
13:18
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Network, nodes and nexus: systems approach to multitarget therapeutics
Divya Murthy1, Kuldeep Singh Attri, Rajesh S Gokhale
1CSIR-Institute of Genomics and Integrative Biology, Mall Road, Delhi, India.
Current Opinion in Biotechnology
|March 5, 2013
Summary
Systems biology reveals dynamic regulatory networks influenced by genes and environment. Understanding these complex molecular circuitries is crucial for developing multi-target therapies against diseases like cancer and tuberculosis.
Area of Science:
- Systems biology
- Genomics
- Metabolic engineering
Background:
- Biological systems exhibit complex regulatory networks with spatiotemporal variations.
- Gene-environment interactions significantly impact cellular emergent properties.
- Metabolic networks dynamically adapt to environmental changes, including infections.
Purpose of the Study:
- To emphasize the need for a dynamic understanding of molecular circuitries.
- To highlight the role of metabolic network adaptation in disease phenotypes.
- To advocate for advanced therapeutic strategies against complex disorders.
Main Methods:
- Analysis of regulatory network dynamics.
- Investigation of metabolic network adaptation mechanisms.
- Exploration of disease progression profiles in complex disorders.
Main Results:
- Spatiotemporal variations in regulatory networks are increasingly understood.
- Metabolic network adaptability is a key factor in disease development (e.g., tuberculosis, cancer).
- Dynamic disease profiles are essential for effective therapeutic development.
Conclusions:
- Effective therapeutics for complex diseases require understanding dynamic network adaptations.
- Multi-target systemic therapies are necessary to overcome pathway redundancy and adaptation.
- Integrating systems biology approaches is vital for advancing personalized medicine.
Related Concept Videos
02:26Protein Networks
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...